[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO965516D0 - Sterolderivater anvendt til regulering av meiose - Google Patents

Sterolderivater anvendt til regulering av meiose

Info

Publication number
NO965516D0
NO965516D0 NO965516A NO965516A NO965516D0 NO 965516 D0 NO965516 D0 NO 965516D0 NO 965516 A NO965516 A NO 965516A NO 965516 A NO965516 A NO 965516A NO 965516 D0 NO965516 D0 NO 965516D0
Authority
NO
Norway
Prior art keywords
sterol derivatives
derivatives used
regulate meiosis
meiosis
regulate
Prior art date
Application number
NO965516A
Other languages
English (en)
Other versions
NO965516L (no
NO314534B1 (no
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO965516D0 publication Critical patent/NO965516D0/no
Publication of NO965516L publication Critical patent/NO965516L/no
Publication of NO314534B1 publication Critical patent/NO314534B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19965516A 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro NO314534B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number Publication Date
NO965516D0 true NO965516D0 (no) 1996-12-20
NO965516L NO965516L (no) 1997-02-21
NO314534B1 NO314534B1 (no) 2003-04-07

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965516A NO314534B1 (no) 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro

Country Status (26)

Country Link
US (1) US5716777A (no)
EP (1) EP0767798B1 (no)
JP (1) JP3987105B2 (no)
KR (1) KR100408369B1 (no)
CN (1) CN1068333C (no)
AT (1) ATE248852T1 (no)
AU (1) AU694240B2 (no)
BG (1) BG101067A (no)
BR (1) BR9508074A (no)
CA (1) CA2192941C (no)
CZ (1) CZ289407B6 (no)
DE (1) DE69531682T2 (no)
DK (1) DK0767798T3 (no)
ES (1) ES2204955T3 (no)
FI (1) FI117159B (no)
HU (1) HUT76343A (no)
IL (1) IL114294A (no)
IS (1) IS4404A (no)
MX (1) MX9700174A (no)
NO (1) NO314534B1 (no)
PL (1) PL186688B1 (no)
RU (1) RU2194510C2 (no)
SI (1) SI9520077A (no)
SK (1) SK165596A3 (no)
UA (1) UA51622C2 (no)
WO (1) WO1996000235A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980702624A (ko) * 1995-03-06 1998-08-05 슈타르 피아 감수분열의 자극
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU718246B2 (en) * 1995-06-23 2000-04-13 Novo Nordisk A/S Meiosis regulating compounds
HUP9904616A3 (en) 1996-12-20 2001-02-28 Novo Nordisk As Meiosis regulating cholestane-derivatives
TR199902793T2 (xx) * 1997-05-16 2000-06-21 Akzo Nobel N.V. 20-Aralkil-5alfa-pregnan t�revleri.
EP0988312B1 (en) * 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
ES2181321T3 (es) * 1997-12-18 2003-02-16 Akzo Nobel Nv Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
ATE256144T1 (de) * 1998-05-13 2003-12-15 Novo Nordisk As Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
AU5408999A (en) * 1998-05-26 1999-12-13 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
CA2335329A1 (en) * 1998-06-19 1999-12-29 Novo Nordisk A/S Meiosis regulating compounds
WO2000035938A1 (en) * 1998-12-11 2000-06-22 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
SK11382001A3 (sk) * 1999-02-10 2002-01-07 Schering Aktiengesellschaft Nenasýtené cholestánové deriváty, farmaceutické kompozície obsahujúce tieto deriváty a použitie týchto derivátov na prípravu liečiv regulujúcich meiózu
DE60034662T2 (de) * 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
DE60025905T2 (de) * 1999-02-24 2006-09-14 Novo Nordisk A/S In vitro methode zur synchronisation von oozytenreifung
JP2002537801A (ja) * 1999-02-26 2002-11-12 ノボ ノルディスク アクティーゼルスカブ 着床率を増大させる減数分裂活性化ステロール
DE60000978T2 (de) * 1999-03-09 2003-07-17 Akzo Nobel N.V., Arnheim/Arnhem 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
MXPA02002439A (es) * 1999-09-16 2002-07-30 Novo Nordisk As Composicion para fertilizacion in vitro.
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
CA2399036A1 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
CA2404822A1 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
BR9508074A (pt) 1997-08-12
ATE248852T1 (de) 2003-09-15
EP0767798B1 (en) 2003-09-03
FI117159B (fi) 2006-07-14
AU2734395A (en) 1996-01-19
NO965516L (no) 1997-02-21
CN1068333C (zh) 2001-07-11
ES2204955T3 (es) 2004-05-01
DE69531682T2 (de) 2004-07-15
JP3987105B2 (ja) 2007-10-03
DE69531682D1 (de) 2003-10-09
SI9520077A (sl) 1998-06-30
DK0767798T3 (da) 2003-12-22
KR100408369B1 (ko) 2004-04-28
PL186688B1 (pl) 2004-02-27
IL114294A0 (en) 1995-10-31
PL317830A1 (en) 1997-04-28
HUT76343A (en) 1997-08-28
CN1151164A (zh) 1997-06-04
BG101067A (en) 1997-08-29
MX9700174A (es) 1997-04-30
IS4404A (is) 1996-12-23
CZ289407B6 (cs) 2002-01-16
FI965144A0 (fi) 1996-12-20
CA2192941C (en) 2009-04-14
HU9603584D0 (en) 1997-02-28
US5716777A (en) 1998-02-10
RU2194510C2 (ru) 2002-12-20
JPH10502060A (ja) 1998-02-24
AU694240B2 (en) 1998-07-16
EP0767798A1 (en) 1997-04-16
CA2192941A1 (en) 1996-01-04
WO1996000235A1 (en) 1996-01-04
FI965144A (fi) 1997-02-20
IL114294A (en) 2002-09-12
SK165596A3 (en) 1997-08-06
CZ372596A3 (en) 1997-07-16
NO314534B1 (no) 2003-04-07
UA51622C2 (uk) 2002-12-16

Similar Documents

Publication Publication Date Title
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
IT1285770B1 (it) Composti corticoidei
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
MX9700885A (es) Nuevas heteroariloxazolidinonas.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de) Thiazolopyrimidinderivate
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
SE9801494D0 (sv) Novel use
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE227122T1 (de) Stabilisierte tablettenformulierung
FI923751A (fi) Hexahydrobenso/f/kinolinoner
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat